Market Place
Sourcing Support
Biocon accused of IP theft to create cancer biotech Bicara
24 Oct 2024 //
FIERCE BIOTECH
Biocon Report Explores Pathways To Increase Biosimilar Adoption
09 Oct 2024 //
EXPRESSPHARMA
FDA Issues Form 483 to Biocon Sdn.
07 Oct 2024 //
FDA
Biocon unit gets USFDA nod for generic drug
02 Sep 2024 //
ECONOMICTIMES
Biocon`s Generics Sacubitril; Valsartan Receives Approval in US
30 Aug 2024 //
FDA
Biocon`s Generics Daptomycin Receives Approval in US
29 Aug 2024 //
FDA
Biocon Settles With Janssen To Sell Biosimilars In Multiple Regions
29 Aug 2024 //
CONTRACT PHARMA
Biocon arm`s growth formula: US rollouts & debt reduction
12 Aug 2024 //
ECONOMICTIMES
Biocon posts Q1 FY25 PAT higher at Rs. 660 Cr
11 Aug 2024 //
INDIANPHARMAPOST
USFDA observations for Biocon Biologics unit. Details here
08 Aug 2024 //
CNBCTV18
India`s Biocon posts Q1 profit rise on sale of branded formulations business
08 Aug 2024 //
REUTERS
Biocon`s Generics Lenalidomide Receives Tentative Approval in US
02 Aug 2024 //
FDA
Biocon Foundation And IISc Lead AI-Center Of Excellence Project
30 Jul 2024 //
PHARMABIZ
USFDA completes inspection at Biocon Biologics’ facilities in Bengaluru
29 Jul 2024 //
INDIANPHARMAPOST
Biocon Gets 4 Observations From USFDA For Andhra Pradesh Facility
22 Jun 2024 //
ECONOMICTIMES
Biocon seeks partner to test generic Wegovy, Ozempic in China
21 Jun 2024 //
MONEYCONTROL
Biocon inks licensing, supply pact Handok for chronic weight management product
24 May 2024 //
PRESS RELEASE
US FDA approves two biosimilars for blockbuster eye drug Eylea
21 May 2024 //
REUTERS
Acceleration of biosimilar business, debt reduction priorties in FY25: Biocon
18 May 2024 //
ECONOMICTIMES
Biocon net profit for Q4 declines 56%
16 May 2024 //
PHARMABIZ
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Biocon receives approval from SAHPRA for Tacrolimus Capsule
22 Apr 2024 //
INDINPHARMAPOST
India`s Biocon developing its own version of Wegovy, trial likely next year
18 Apr 2024 //
REUTERS
Biocon partners Biomm to commercialise diabetes drug in Brazil
17 Apr 2024 //
ECONOMICTIMES
Biocon leads India`s push into anti-obesity drugs as patents lapse
08 Apr 2024 //
BUSINESS STANDARD
Biocon to obtain approval for diabetes drug, Liraglutide in UK
28 Mar 2024 //
INDINPHARMAPOST
Biocon to sell branded formulations business to Eris Lifesciences for $150 mln
13 Mar 2024 //
REUTERS
Novo Nordisk tackles harm from Ozempic fakes with global authorities
09 Mar 2024 //
REUTERS
Biocon gets over Rs 3 crore penalty over GST related issues
23 Feb 2024 //
ECONOMIC TIMES
India`s Biocon posts profit on biosimilar boost, divestment gains
08 Feb 2024 //
REUTERS
Biocon CFO Indranil Sen resigns
08 Feb 2024 //
ENDPTS
Pharma industry can be worth $200B by 2030,says Biocon chief Kiran Mazumdar-Shaw
24 Jan 2024 //
ECONOMIC TIMES
Biocon Academy conducts 8th Graduation Day
19 Dec 2023 //
INDIAN PHARMA POST
Biocon weighs sale of $1.5 billion generic API business
15 Dec 2023 //
ECONOMIC TIMES
Biocon denies plans to sell $1.5 billion generic API business
15 Dec 2023 //
ECONOMIC TIMES
Biocon looking at options to cut debt taken for Viatris` business buy`
17 Nov 2023 //
ECONOMIC TIMES
India`s Biocon misses Q2 profit view on higher expenses
09 Nov 2023 //
REUTERS
Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
09 Oct 2023 //
ECONOMIC TIMES
USFDA issues CRL for proposed biosimilar Insulin Aspart: Biocon
09 Oct 2023 //
ECONOMICS TIMES
Biocon`s Peter Bains jumps from the board to group CEO
19 Sep 2023 //
FIERCE PHARMA
Biocon appoints Peter Bains as Group CEO
18 Sep 2023 //
ECONOMIC TIMES
Biocon acquires Eywa Pharma`s US-based plant for $7.7 million
02 Sep 2023 //
ECONOMIC TIMES
FDA Issues Form 483 to Biocon Sdn. Bhd.
14 Aug 2023 //
FDA
Biocon Announces Positive CHMP Opinion for YESAFILI, Biosimilar Aflibercept
25 Jul 2023 //
PR NEWSWIRE
Govt grants sanction to prosecute joint drugs controller S Eswara Reddy
23 Jul 2023 //
ECONOMIC TIMES
Biocon Biologics gets 8 observations from USFDA for Malaysia insulin facility
21 Jul 2023 //
ECONOMIC TIMES
Biocon Biologics takes over Viatris` biosimilar biz in over 70 countries
05 Jul 2023 //
ECONOMIC TIMES
India`s Biocon Biologics launches biosimilar for AbbVie`s Humira in US
04 Jul 2023 //
ECONOMIC TIMES
Biocon Group concludes month-long sustainability initiatives commemorating WED
01 Jul 2023 //
EXPRESS PHARMA
Biocon may raise additional equity of $300 million in FY24 to pare debt
25 May 2023 //
ECONOMIC TIMES
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
24 May 2023 //
INDIAN PHARMA POST
CCI clears Edelweiss-Biocon Biologics deal
10 May 2023 //
EXPRESS PHARMA
Biocon`s Generic Lenalidomide Receives Receives Approval in the U.S.
04 May 2023 //
FDA
Biocon Generic Lenalidomide Receives Approval in the U.S
04 May 2023 //
FDA
Biocon Biologics facility gets EU GMP certification for Bevacizumab
29 Apr 2023 //
HEALTH ET
Serum Institute doubles its stake in Biocon Biologics to $300M
25 Apr 2023 //
FIERCE PHARMA
Biocon` Generic Teriflunomide Receives Approval in the U.S.
13 Mar 2023 //
FDA
Biocon raises $129 million from Kotak to fund biosimilars deal
22 Feb 2023 //
ECONOMIC TIMES
Biocon Q3 FY23 revenue up 36%
17 Feb 2023 //
INDIAN PHARMA POST
Biocon Biologics has comprehensive plan to integrate Viatris business
16 Feb 2023 //
ECONOMIC TIMES
